Voya Investment Management LLC Genprex, Inc. Transaction History

Voya Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $43,595 - $68,267	-14,018 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.03 - $5.51 $7,656 - $13,923	2,527 Added 21.99%	14,018 $58,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $3.64 $22,867 - $41,827	11,491 New	11,491 $36,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $39.9M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.